Skip to main content
. 2014 Oct 13;7:1875–1881. doi: 10.2147/OTT.S66525

Figure 3.

Figure 3

PFS of second-line docetaxel-based treatment according to first-line efficacy (3.6 vs 2.2 months, P=0.005). Abbreviation: PFS, progression-free survival.